Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02028256
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
368 | (1R)-2-{[AMINO(IMINO)METHYL]AMINO}- 1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2- DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE | A | 1ZLR | 0.77 | |
NCA | NICOTINAMIDE | A,B | 2E5D | 0.75 | |
NCA | NICOTINAMIDE | A,B,C,D | 2Z77 | 0.75 | |
NCA | NICOTINAMIDE | A,B | 1DMA | 0.75 | |
NCA | NICOTINAMIDE | A,B | 1ISM | 0.75 | |
NCA | NICOTINAMIDE | A,B | 1YC5 | 0.75 | |
NCA | NICOTINAMIDE | A | 2ZB7 | 0.75 | |
NCA | NICOTINAMIDE | A,B,C,D,E,F, G,H | 1R15 | 0.75 | |
NCA | NICOTINAMIDE | A,B | 2QQG | 0.75 | |
NCA | NICOTINAMIDE | A | 2OTV | 0.75 | |
NCA | NICOTINAMIDE | A | 2QHF | 0.75 | |
NCA | NICOTINAMIDE | A,B,C,D | 2C8A | 0.75 | |
NCA | NICOTINAMIDE | A,B | 2HJH | 0.75 | |
NCA | NICOTINAMIDE | A | 2A15 | 0.75 | |
NCA | NICOTINAMIDE | A | 2R6V | 0.75 | |
NCA | NICOTINAMIDE | A,B | 1ISI | 0.75 | |
NCA | NICOTINAMIDE | A,D,E | 2R9J | 0.75 | |
NCA | NICOTINAMIDE | A | 2H4J | 0.75 | |
NCA | NICOTINAMIDE | A,B | 2OD9 | 0.75 | |
NCA | NICOTINAMIDE | A,B,C,D,E | 1YC2 | 0.75 | |
NCA | NICOTINAMIDE | A,B | 3DZG | 0.75 | |
NCA | NICOTINAMIDE | A | 1OJU | 0.75 | |
LG4 | 5-METHYLPYRIDIN-2-AMINE | A | 2EUP | 0.73 | |
G14 | 2-phenyl-1H-imidazole-4-carboxylic acid | A,B | 3GRJ | 0.71 | |
OPN | {(2-AMINO-ETHYL)-[2-(2-OXO-1,2- DIHYDRO-[1,8]NAPHTHYRIDIN-3-YL)- ACETYL]-AMINO}-ACETIC ACID | A,B,C,D | 1HZS | 0.73 | |
PYF | 3-PYRIDINYLCARBINOL | A,B | 1R16 | 0.74 | |
PD8 | PHOSPHORYLATED DIHYDROPTEROATE | A | 1W78 | 0.72 | |
PAQ | 2-OXY-4-HYDROXY-5-(2-HYDRAZINOPYRIDINE)PHENYLALANINE | A,B,C,D | 2C11 | 0.71 | |
PAQ | 2-OXY-4-HYDROXY-5-(2-HYDRAZINOPYRIDINE)PHENYLALANINE | A,B | 1SPU | 0.71 | |
24X | H,L | 2EC9 | 0.79 | ||
NIX | NALIDIXIC ACID | A,B | 2BQ2 | 0.76 | |
PMC | 3-(PHOSPHONOMETHYL)PYRIDINE-2-CARBOXYLIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1I43 | 0.73 | |
608 | N-(4-phenoxyphenyl)-2-[(pyridin- 4-ylmethyl)amino]nicotinamide | A,B | 2P2I | 0.71 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z8C | 0.75 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z7L | 0.75 | |
6PC | PYRIDINE-2-CARBOXYLIC ACID | A | 2OLN | 0.73 | |
6PC | PYRIDINE-2-CARBOXYLIC ACID | A | 2OLO | 0.73 | |
PAA | (N-METHYLPYRIDYL)ACETIC ACID | I | 1HBT | 0.76 | |
G44 | 4-({[4-(3-METHYLBENZOYL)PYRIDIN- 2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE | C,D | 2PKS | 0.72 | |
NCN | NICOTINATE MONONUCLEOTIDE | A,B | 2QTN | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4F | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4L | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A,B,C,D | 1YUM | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4M | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A,B,C,D,E,F | 1QPN | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A,B,C | 2B7Q | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4K | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4G | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1YTK | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4H | 0.74 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L5O | 0.74 | |
LG2 | 6-[1-(3,5,5,8,8-PENTAMETHYL-5,6,7,8- TETRAHYDRONAPHTHALEN-2-YL)CYCLOPROPYL]PYRIDINE- 3-CARBOXYLIC ACID | A,B,C,D | 1H9U | 0.73 | |
NA4 | 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)- PYRIDIN-3-YL]-BENZOIC ACID | A,C | 1RHM | 0.72 | |
NA3 | (3S)-3-{[(5-BROMOPYRIDIN-3-YL)CARBONYL]AMINO}- 4-OXOBUTANOIC ACID | A | 1RE1 | 0.7 | |
BVF | 4-METHYLPYRIDIN-2-AMINE | A,B | 3E67 | 0.71 | |
BVF | 4-METHYLPYRIDIN-2-AMINE | A | 2EUT | 0.71 | |
ICO | 1H-INDOLE-3-CARBOXYLIC ACID | L | 2PIP | 0.7 | |
AT2 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE- 1-CARBOXYLATE | A,B | 3E7S | 0.7 | |
AT2 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE- 1-CARBOXYLATE | A,B | 3E7M | 0.7 | |
AT2 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE- 1-CARBOXYLATE | A,B,C,D | 3E7G | 0.7 | |
AXD | 2-[4-({2-[(2S,5R)-2-(AMINOMETHYL)- 5-ETHYNYLPYRROLIDIN-1-YL]-2-OXOETHYL}AMINO)- 4-METHYLPIPERIDIN-1-YL]ISONICOTINIC ACID | B | 2I03 | 0.76 | |
MMG | 4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin- 3-yl)benzoic acid | A | 3HDM | 0.74 | |
859 | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)BENZAMIDE | A,B | 2NO3 | 0.76 | |
PD2 | PYRIDINE-2,4-DICARBOXYLIC ACID | A,B,C | 2W2I | 0.73 | |
PD2 | PYRIDINE-2,4-DICARBOXYLIC ACID | A | 2GKL | 0.73 | |
PD2 | PYRIDINE-2,4-DICARBOXYLIC ACID | A,B | 2VD7 | 0.73 | |
PD2 | PYRIDINE-2,4-DICARBOXYLIC ACID | A,B | 2JIG | 0.73 | |
BFU | 1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6- FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)- CYCLOPROPYL]-UREA | A | 1EET | 0.7 | |
NFL | 2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID | A | 1TD7 | 0.89 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1S1X | 0.74 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWE | 0.74 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LW0 | 0.74 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 2HND | 0.74 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1FKP | 0.74 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1S1U | 0.74 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWF | 0.74 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 2HNY | 0.74 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1VRT | 0.74 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWC | 0.74 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1JLB | 0.74 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 3HVT | 0.74 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1JLF | 0.74 | |
4PP | C,L | 1XKA | 0.7 | ||
4PP | A,B,C,D | 1XKB | 0.7 | ||
NNO | 6-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCK | 0.8 | |
NNO | 6-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCM | 0.8 | |
3HM | 5-hydroxy-6-methylpyridine-3-carboxylic acid | A,B | 3GMC | 0.73 | |
TRN | NZ2-TRYPTOPHAN | A,B,C | 1AM7 | 0.72 | |
7CS | (3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT- 3-YL 1H-PYRROLO[2,3-B]PYRIDINE- 3-CARBOXYLATE | A | 2QHM | 0.72 | |
985 | (2E)-3-{3-[6-(4-methyl-1,4-diazepan- 1-yl)pyrazin-2-yl]phenyl}prop-2- enoic acid | A | 3F2A | 0.71 | |
PRR | 3-(METHYL-PYRIDINIUM)ALANINE | H,I,J | 7KME | 0.73 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 2DHF | 0.73 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 1DYH | 0.73 | |
DZF | 5-DEAZAFOLIC ACID | A,B,C,D | 1CDE | 0.73 | |
NTM | QUINOLINIC ACID | A | 3C2O | 0.78 | |
NTM | QUINOLINIC ACID | A,B | 1QAP | 0.78 | |
NTM | QUINOLINIC ACID | A,B,C,D,E,F | 1QPQ | 0.78 | |
NTM | QUINOLINIC ACID | A,B,C | 2B7N | 0.78 | |
PT1 | PTEROIC ACID | A,B | 1TX0 | 0.71 | |
PT1 | PTEROIC ACID | A | 1BR6 | 0.71 | |
PT1 | PTEROIC ACID | A,B | 1HWP | 0.71 | |
SX2 | 4-[(5-bromopyridin-2-yl)amino]- 4-oxobutanoic acid | A,B | 3CJ0 | 0.72 | |
PBO | 1-PYRIDIN-3-YLBUTAN-1-ONE | A | 1PYJ | 0.73 | |
3BD | 7-amino-2-tert-butyl-4-(4-pyrimidin- 2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine- 6-carboxamide | A | 3BAB | 0.7 | |
NIO | NICOTINIC ACID | A | 1JHQ | 0.88 | |
NIO | NICOTINIC ACID | A | 1L5L | 0.88 | |
NIO | NICOTINIC ACID | A | 2F7F | 0.88 | |
NIO | NICOTINIC ACID | A | 1L5K | 0.88 | |
NIO | NICOTINIC ACID | A | 1JHY | 0.88 | |
NIO | NICOTINIC ACID | A,B | 1FSL | 0.88 | |
NIO | NICOTINIC ACID | A | 1L5M | 0.88 | |
NIO | NICOTINIC ACID | A | 1LH6 | 0.88 | |
NIO | NICOTINIC ACID | A | 1JHO | 0.88 | |
NIO | NICOTINIC ACID | A | 3CI8 | 0.88 | |
NIO | NICOTINIC ACID | A,B,C,D | 1ICU | 0.88 | |
NIO | NICOTINIC ACID | A,B,C,D,E,F, G,H | 3HRD | 0.88 | |
NIO | NICOTINIC ACID | A | 1JHA | 0.88 | |
NIO | NICOTINIC ACID | A | 1JHV | 0.88 | |
NIO | NICOTINIC ACID | A | 1L4N | 0.88 | |
NIO | NICOTINIC ACID | A | 2LH6 | 0.88 | |
NIO | NICOTINIC ACID | A | 1D0V | 0.88 | |
NIO | NICOTINIC ACID | A,B,C,D | 1ICV | 0.88 | |
NIO | NICOTINIC ACID | A,B | 1ICR | 0.88 | |
NIO | NICOTINIC ACID | A | 1JHR | 0.88 | |
INO | 2-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCL | 0.74 | |
INO | 2-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCJ | 0.74 | |
NNR | Nicotinamide riboside | A | 2QT0 | 0.72 | |
NNR | Nicotinamide riboside | A | 2QT1 | 0.72 |